Work

Tisotumab vedotin (TV) in patients with previously treated recurrent or metastatic cervical cancer: Updated safety and efficacy results from the full cervical cohort of the phase II innova TV 201 study (NCT02001623)

Year: 2019

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.04.034

Authors: D.S. Hong, H.T. Arkenau, J. de Bono, U.N. Lassen, Y. Drew, B.M. Slomovitz, S. Ghatta, K. Windfeld, R.A. Rangwala, N. Concin

Institutions: The University of Texas MD Anderson Cancer Center, Sarah Cannon Research Institute, Rigshospitalet, Newcastle University, University of Miami, Sylvester Comprehensive Cancer Center, Genmab (United States), Genmab (Denmark), KU Leuven

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2954934511

FWCI: 0.272

Cites:

Cited by: 2

Related to: 10